|7.66||-0.38 / -4.73%|
As of 3:59pm ET
|7.66||0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 21.50, with a high estimate of 38.00 and a low estimate of 11.00. The median estimate represents a +180.68% increase from the last price of 7.66.
The current consensus among 9 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.